Comparative Review of Dopamine Receptor Agonists in Parkinsonʼs Disease
- 1 May 1996
- journal article
- review article
- Published by Springer Science and Business Media LLC in CNS Drugs
- Vol. 5 (5), 369-388
- https://doi.org/10.2165/00023210-199605050-00006
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Pergolide compared with bromocriptine in Parkinson's disease: A multicenter, crossover, controlled studyMovement Disorders, 1994
- A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's diseaseMovement Disorders, 1994
- Current Status of Dopamine Agonists in Parkinson??s Disease ManagementDrugs, 1993
- Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 ratsNeurobiology of Aging, 1992
- D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal NeuronsScience, 1990
- Comparison of motor response to apomorphine and levodopa in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Recent advances in the treatment of Parkinson's disease: The role of bromocriptineJournal of Neural Transmission, 1981